Ablation of atrial fibrillation (AF) improves quality of life (QOL) more than drugs, according to a study presented on Aug. 29 at the European Society of Cardiology conference. This was the first time that QOL was used as a primary endpoint. The multicenter, randomized trial included 155 patients with symptomatic AF who had failed one drug for either rate or rhythm control. Continue reading
Selected patients on mechanical ventilation may safely self-administer dexmedetomidine to manage their anxiety, according to a study in the American Journal of Critical Care. Most patients were satisfied with their ability to self-administer the medication, and nurses adhered to monitoring safety parameters.
Results The sample was 59% male and 89% white. Mean values were age, 50.6 years; score on the Acute Physiology and Chronic Health Evaluation, 60.1; and protocol duration, 3.4 days. Five dexmedetomidine patients had blood pressure and/or heart rate lower than safety parameters, necessitating short-term treatment. Nurses’ adherence to reporting of safety parameters was 100%; adherence to the dexmedetomidine titration algorithm was 73%. Overall baseline anxiety score was 38.4 and did not change significantly (βday = 2.1; SE, 2.5; P = .40). Most dexmedetomidine patients (92%) were satisfied or very satisfied with their ability to self-administer medication.
read the report at acc.aacnjournals.org
On March 15, the Centers for Disease Control and Prevention (CDC) released “CDC Guideline for Prescribing Opioids for Chronic Pain, United States, 2016.” Read more
On March 9, the Centers for Disease Control and Prevention (CDC) released “Zika virus risk-based preparedness and response guidance for states.” Read more